Eli Lilly & Co (NYSE: LLY) xaus me ntsis rau hnub Friday tom qab US FDA tsis lees txais nws qhov kev thov kom nrawm pom zoo rau Donanemab - nws cov tshuaj Alzheimer.
Vim li cas FDA tsis kam lees nws daim ntawv thov?
Raws li Lub Chaw Tswj Xyuas Khoom Noj thiab Tshuaj, cov kws tshuaj behemoth tsis muaj cov ntaub ntawv txaus los ua pov thawj pom zoo sai. Tshwj xeeb, tus tswj hwm xav kom Lilly kho yam tsawg kawg 100 tus neeg nrog Donanemab rau kaum ob lub hlis lossis ntau dua.
Puas yog koj tab tom nrhiav kom tau cov xov xwm ceev, kub-cov lus qhia thiab kev tsom xam kev ua lag luam?
Sau npe rau Invezz cov ntawv xov xwm, hnub no.
Theem II cov ntaub ntawv uas Indiana-based Eli Lilly xa poob rau ntawm qhov pib. Hauv xovxwm tso tawm, Anne White - Tus Lwm Thawj Coj Thawj Coj ntawm lub tuam txhab tau hais tias:
Peb tos ntsoov rau peb qhov kev lees paub yav tom ntej Theem 3 thiab kev xa tawm FDA tom ntej. Peb tau cog lus tias yuav ua haujlwm nrog FDA los xyuas kom meej txoj hauv kev sai tshaj plaws los nqa cov tshuaj no rau cov neeg mob xav tau.
Lilly Tshuag tam sim no nce ntau dua 15% piv rau lub Cuaj Hli.
Koj puas tseem yuav tau Lilly Tshuag?
Txawm hais tias muaj kev poob qis, Bank of America tus kws tshuaj ntsuam Geoff Meacham tseem muaj kev cia siab rau pharma khoom rau nws cov tshuaj Mounjaro.
Mounjaro yog Lilly cov tshuaj ntshav qab zib hom 2 uas zoo li yuav tau txais kev pom zoo los kho kev rog rog hauv qab ib nrab xyoo 2023 (Nyeem Ntxiv).
Nws yeej tsis yog thesis-breaker. Cov neeg siv tsis muaj zog los yuav cov Tshuag, thiab nws yog tiag tiag vim hais tias cov lus piav qhia ntawm kev rog rog thiab ntawm Mounjaro tso tawm tsuas yog muaj zog heev.
Eli Lilly & Co tsis tau txo nws cov kev taw qhia nyiaj txiag puv xyoo tom qab FDA tsis lees paub. Meacham tam sim no muaj lub hom phiaj tus nqi ntawm $ 390 ib feem ntawm Lilly Tshuag, uas sawv cev txog 13% upside ntawm no.
Tau qhov twg los: https://invezz.com/news/2023/01/21/buy-lilly-stock-despite-alzheimers-drug-setback/